Consumers across Europe furious over President Donald Trump’s policies are boycotting U.S. goods. Among the most passionate ...

Considering this and Viking's clinical trial advancements, is the stock a buy right now? First, let's back up and take a look at the company's story over the past year. Viking shares originally ...

Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Last week, though, Viking shares popped in one trading session, climbing as much as 15% ...

Considering this and Viking's clinical trial advancements, is the stock a buy right now? Image source: Getty Images. First, let's back up and take a look at the company's story over the past year.

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report). The company’s shares closed yesterday at $26.52. Effectively ...

On Tuesday, H.C. Wainwright reaffirmed its Buy rating on Viking Therapeutics (NASDAQ:VKTX), with a steady price target of $102.00. Currently trading at $27.96, the stock has significant upside ...

Shares of NASDAQ:VKTX opened at $26.52 on Tuesday. Viking Therapeutics has a 12-month low of $24.41 and a 12-month high of $89.10. The business has a 50 day moving average of $32.88 and a two ...